Changes in the shbg concentration during danazol treatment
Danazol treatment rapidly and proportionally decreased serum sex hormone binding globulin levels in a dose-dependent manner in both pre- and postmenopausal women, suggesting direct hepatic synthesis inhibition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity via openalex
- Danazol—a Synthetic Steroid Derivative with Interesting Physiologic Properties via openalex
- Danazol binding and translocation of steroid receptors via openalex
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic Activity via openalex
- Danazol Suppresses Luteal Function in Vitro and in Vivo via openalex
- Danazol suppression of luteinizing hormone secretion: a role for danazol-androgen receptor interaction within the brain-pituitary complex via openalex
- Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3′,5′ cyclic monophosphate formation via openalex
- Free testosterone levels during danazol therapy via openalex
- Hormonal effects of danazol and medical oophorectomy in endometriosis. via openalex
- Inhibition of steroid sulfatase activity by danazol via openalex
- In vitro effect of danazol on steroidogenesis in developing human follicles via openalex
- Mechanism of induction of luteal phase defects by danazol via openalex
- Peripheral androgen levels in danazol-treated premenopausal women via openalex
- The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women via openalex
- Transport of Steroid Hormones: Interaction of 70 Drugs with Testosterone-Binding Globulin and Corticosteroid-Binding Globulin in Human Plasma via openalex
- doi:10.1530/acta.0.0880190 via openalex
- doi:10.1111/j.1365-2265.1981.tb02966.x via openalex
- doi:10.1016/s0002-9378(16)32379-1 via openalex
- doi:10.1016/s0015-0282(16)43869-0 via openalex
- doi:10.3109/00016348409156998 via openalex
- doi:10.1016/0002-9378(81)90611-6 via openalex
- doi:10.3109/00365518409083783 via openalex
- doi:10.1210/jcem-52-5-868 via openalex
Cited by (8)
- A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas 2002
- Plasma protein changes induced by two orally administered androgen derivatives 1996
- Glucose tolerance and insulin resistance after danazol treatment 1989
- Danazol concentrations in human ovarian follicular fluid and their relationship to simultaneous serum concentrations 1988
- Endocrine consequences of danazol treatment in menorrhagia 1986
- A COMPARISON OF THE EFFECTS OF DANAZOL AND GESTRINONE ON TESTOSTERONE BINDING TO SEX HORMONE BINDING GLOBULIN <i>IN VITRO</i> AND <i>IN VIVO</i> 1986
- Biochemical Basis for the Antagonism between Aminoglutethimide and Danazol in the Endocrine Treatment of Breast Cancer 1986
- Danazol treatment of severely symptomatic fibrocystic breast disease and long‐term follow‐up—the Hjørring project 1984
Source provenance
- openalex
- last seen: 2026-05-10T11:11:16.805475+00:00